(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.82%) $83.16
(-1.16%) $1.619
(-0.30%) $2 340.10
(0.98%) $27.52
(0.59%) $927.50
(-0.19%) $0.933
(-0.19%) $11.00
(-0.27%) $0.798
(0.00%) $92.17
4.87% INR 122.65
Live Chart Being Loaded With Signals
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches...
Stats | |
---|---|
Tagesvolumen | 1.10M |
Durchschnittsvolumen | 644 285 |
Marktkapitalisierung | 12.84B |
EPS | INR0 ( 2024-01-22 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-08 |
Last Dividend | INR0.500 ( 2023-07-12 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 14.78 |
ATR14 | INR0.298 (0.24%) |
Volumen Korrelation
Bliss GVS Pharma Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Bliss GVS Pharma Limited Korrelation - Währung/Rohstoff
Bliss GVS Pharma Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR7.52B |
Bruttogewinn: | INR3.50B (46.60 %) |
EPS: | INR6.83 |
FY | 2022 |
Umsatz: | INR7.52B |
Bruttogewinn: | INR3.50B (46.60 %) |
EPS: | INR6.83 |
FY | 2022 |
Umsatz: | INR7.38B |
Bruttogewinn: | INR3.47B (47.02 %) |
EPS: | INR2.24 |
FY | 2021 |
Umsatz: | INR5.69B |
Bruttogewinn: | INR2.40B (42.16 %) |
EPS: | INR6.64 |
Financial Reports:
No articles found.
Bliss GVS Pharma Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.300 | 2010-11-25 |
Last Dividend | INR0.500 | 2023-07-12 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | INR9.35 | -- |
Avg. Dividend % Per Year | 0.46% | -- |
Score | 2.16 | -- |
Div. Sustainability Score | 4.34 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 4.29 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.000 | 0.48% |
2019 | INR1.000 | 0.61% |
2020 | INR0.500 | 0.34% |
2021 | INR1.000 | 0.49% |
2022 | INR1.000 | 0.96% |
2023 | INR0.500 | 0.69% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SANDHAR.NS | Dividend Junior | 2023-09-14 | Annually | 7 | 0.66% | |
LXCHEM.NS | Dividend Junior | 2023-07-20 | Annually | 4 | 0.11% | |
GLENMARK.NS | Dividend Junior | 2023-09-18 | Annually | 23 | 0.37% | |
ASIANPAINT.NS | Dividend Junior | 2023-06-09 | Semi-Annually | 23 | 0.43% | |
TINPLATE.NS | Dividend Junior | 2023-08-11 | Annually | 19 | 0.72% | |
PDMJEPAPER.NS | Dividend Junior | 2023-08-03 | Annually | 9 | 0.65% | |
J&KBANK.NS | Dividend Junior | 2023-08-17 | Sporadic | 22 | 0.47% | |
DATAMATICS.NS | Dividend Junior | 2023-09-22 | Annually | 21 | 0.49% | |
SHYAMMETL.NS | Dividend Junior | 2023-06-05 | Semi-Annually | 4 | 0.70% | |
MAXHEALTH.NS | Dividend Junior | 2023-09-08 | Insufficient data to determine frequency | 2 | 0.07% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.116 | 1.500 | 7.68 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.129 | 1.500 | 9.68 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 12.33 | 1.000 | 6.54 | 6.54 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.70 | 2.00 | 9.10 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.70 | 2.00 | 8.65 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.477 | 1.000 | 5.38 | 5.38 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.69 | 8.69 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.59 | 1.000 | 8.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.129 | 2.50 | 9.79 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.70 | 2.00 | 9.10 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.408 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.70 | 2.00 | 9.10 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0397 | 1.500 | -3.07 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0373 | 1.000 | -1.566 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.